article thumbnail

Inclusive Innovation: Key to the Future of Healthcare

Fierce Pharma

Inclusive Innovation: Key to the Future of Healthcare jpiatt Fri, 04/05/2024 - 10:37

article thumbnail

Pharma firepower, M&A surge last year bode well for dealmaking prospects in 2024: EY

Fierce Pharma

Morgan Healthcare Conference. | In it’s annual Firepower report, EY says the biopharma industry enters 2024 with the capability and motivation to increase M&A activity. The late surge of activity in 2023 also bodes well for a 2024 uptick, the group said.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

5 Trends Shaping Healthcare Business Strategies for 2024

MedCity News

Deloitte released a report predicting the key trends that will shape the healthcare landscape in 2024. Some of them include hospital M&A, health systems outsourcing departments and the increasing adoption of generative AI tools.

article thumbnail

Telehealth, Patient Reviews, and Retailization – 2024 Healthcare Digital Marketing Trends

MedCity News

Here are 5 healthcare marketing trends to pay attention to in 2024. To meet evolving consumer expectations, providers must have a strong digital marketing strategy and user experience online.

Retail 117
article thumbnail

Predictions for Healthcare Price Transparency in 2024

MedCity News

In looking ahead to 2024, the healthcare industry stands at the cusp of a transformative era of transparency. With impending regulatory changes and growing consumer empowerment, the landscape is poised for continued meaningful progress.

article thumbnail

West Monroe’s 3 Healthcare Outlooks for 2024: AI, Cost Pressures, Dealmaking

MedCity News

There are three key trends for the healthcare industry to follow in 2024, including the rise of AI, increasing cost pressures and M&A activity, according to West Monroe.

article thumbnail

Report: Improving Health Equity is a Top-10 Goal for Most Healthcare Execs in 2024

MedCity News

A recent Deloitte report found that improving health equity is a top-10 goal for 83% of life sciences and healthcare C-suite executives in 2024. The report also laid out factors that will likely influence health equity in 2024, including AI.